Uğur Eskiocak
Therapeutics Clinical Research
ORCID: 0000-0003-3785-5275Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer”.
Miso Park, Magali Pederzoli-Ribeil, Uğur Eskiocak, Parker Johnson, Wilson Guzman +14 more
Andrew R. Jamieson, Erik S. Welf, Andres Nevarez, Justin Cillay, Uğur Eskiocak +3 more
Jessica A. Mine, Subir Biswas, Ricardo A. Chaurio, Alfredo Perales‐Puchalt, Carmen M. Anadon +22 more
Zhaohuan Zhang, Tomoyuki Mashimo, Bo Shen, James O. Nyagilo, Hao Wang +16 more
Andrew R. Jamieson, Erik S. Welf, Andres Nevarez, Justin Cillay, Uğur Eskiocak +3 more